Literature DB >> 24229703

Sox4you: a new player in C/EBPα leukemia.

Tsz Kan Fung1, Anskar Yu Hung Leung, Chi Wai Eric So.   

Abstract

Although CEBPA mutations are among the most common genetic abnormalities in acute myeloid leukemia (AML), the transformation mechanism remains largely obscure. In this issue of Cancer Cell, Zhang and colleagues report that SOX4 is a direct target and crucial mediator of C/EBPα mutants in AML, revealing a potential therapeutic avenue.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24229703     DOI: 10.1016/j.ccr.2013.10.016

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  3 in total

1.  MicroRNA-204 inhibits cell proliferation in T-cell acute lymphoblastic leukemia by down-regulating SOX4.

Authors:  Jun-Jie Yin; Bo Liang; Xin-Rong Zhan
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish.

Authors:  J-W Lu; M-S Hsieh; H-A Hou; C-Y Chen; H-F Tien; L-I Lin
Journal:  Blood Cancer J       Date:  2017-08-25       Impact factor: 11.037

Review 3.  A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology.

Authors:  Hala Skayneh; Batoul Jishi; Rita Hleihel; Maguy Hamieh; Nadine Darwiche; Ali Bazarbachi; Marwan El Sabban; Hiba El Hajj
Journal:  Genes (Basel)       Date:  2019-08-13       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.